Scott Lyman

Chief Business Officer at Grid Therapeutics - Durham, NC, US

Scott Lyman's Colleagues at Grid Therapeutics
Edward Patz

Chief Executive Officer

Contact Edward Patz

Thomas Patz

Chief Operating Officer and General Counsel

Contact Thomas Patz

Scott Lyman's Contact Details
HQ
919-987-7190
Location
Raleigh,North Carolina,United States
Company
Grid Therapeutics
Scott Lyman's Company Details
Grid Therapeutics logo, Grid Therapeutics contact details

Grid Therapeutics

Durham, NC, US • 5 - 9 Employees
BioTech/Drugs

Grid Therapeutics is a biotech company based on the innovative science first developed by Edward F. Patz, Jr. MD and his team of scientists at Duke University Medical Center. Located in Durham, North Carolina, Grid is developing the first human derived targeted immunotherapy for cancer. The antibody was discovered in exceptional outcome early stage lung cancer patients who did not progress to develop metastasis. The antibody was isolated from patient's B-cells using state of the art molecular genomic techniques. "GT103", the company's lead asset, is currently enrolling the first-in-man Phase 1 clinical trial in refractory NSCLC patients.

N/A
Details about Grid Therapeutics
Frequently Asked Questions about Scott Lyman
Scott Lyman currently works for Grid Therapeutics.
Scott Lyman's role at Grid Therapeutics is Chief Business Officer.
Scott Lyman's email address is ***@gridthr.com. To view Scott Lyman's full email address, please signup to ConnectPlex.
Scott Lyman works in the Research industry.
Scott Lyman's colleagues at Grid Therapeutics are Edward Patz, Thomas Patz, Michael Campa and others.
Scott Lyman's phone number is 919-987-7190
See more information about Scott Lyman